Trump has officially nominated Dr. Heidi Overton as the FDA commissioner. Overton previously called the abortion pill “telebortion,” and called on Congress to strictly regulate it.
With the FDA currently reevaluating its approval of mifepristone and its regulations permitting providers to mail the medication, Overton’s nomination represents yet another challenge to mifepristone’s widespread usage—accounting for over two-thirds of all abortions, including in states with bans. Not to mention the fact that Overton also recently appeared next to Trump during a press conference in which he spouted dangerous misinformation about childhood vaccines.
Asking for a friend: Will the physician in the Senate who holds a key vote on the Health Committee cave again?
Meanwhile, the Supreme Court might be on summer break—but its shadow docket is still up and running. And nothing is certain before this Supreme Court, which has committed itself to expanding Trump’s executive powers.
Thanks to SCOTUS and state legislators’ rollback of many fundamental rights, state supreme court races have been receiving increased attention, and attracted significant outside spending.











